FILE:HCP/HCP-8K-20101214075510.txt.gz
EVENTS:	Regulation FD Disclosure	Financial Statements and Exhibits
TEXT:
ITEM: Regulation FD Disclosure
ITEM: Financial Statements and Exhibits
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
o
           
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
o
           
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
o
           
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
 
o
           
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
 
 
 
Item 7.01  Regulation FD Disclosure.
 
On December 13, 2010, HCP, Inc. (the "Company") announced that it entered into a definitive agreement to acquire substantially all of the real estate assets of HCR ManorCare, Inc.  Also on December 13, 2010, the Company announced that it had entered into a definitive agreement to acquire its partner's 65% interest in a joint venture. A copy of a presentation related to these acquisitions will be available on December 14, 2010 on the Company's website in the "Presentations" section of the "Investor Relations" tab and is furnished herewith as Exhibit 99.1 and is incorporated herein by reference.
 
The information disclosed under this Item 7.01, including Exhibit 99.1 hereto, is being furnished and shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and shall not be deemed incorporated by reference into any filing under the Securities Act of 1933, as amended, except as expressly set forth by specific reference in such filing.
 
Item 9.01  Financial Statements and Exhibits.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
Date:  December 14, 2010
 
 

Exhibit 99.1
 


